204 related articles for article (PubMed ID: 20024165)
61. Intraoperative phototherapy: a comparative study of intravenous and topical photofrin II and aminolevulinic acid.
Davis RK; Straight R; Sun Y
Otolaryngol Head Neck Surg; 1997 Feb; 116(2):223-7. PubMed ID: 9051068
[TBL] [Abstract][Full Text] [Related]
62. In vitro and in vivo photosensitizing capabilities of 5-ALA versus photofrin in vascular endothelial cells.
Chang CJ; Sun CH; Liaw LH; Berns MW; Nelson JS
Lasers Surg Med; 1999; 24(3):178-86. PubMed ID: 10229148
[TBL] [Abstract][Full Text] [Related]
63. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
Allison RR; Sibata CH
Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
[TBL] [Abstract][Full Text] [Related]
64. Subcellular localization of Photofrin and aminolevulinic acid and photodynamic cross-resistance in vitro in radiation-induced fibrosarcoma cells sensitive or resistant to photofrin-mediated photodynamic therapy.
Wilson BC; Olivo M; Singh G
Photochem Photobiol; 1997 Jan; 65(1):166-76. PubMed ID: 9066298
[TBL] [Abstract][Full Text] [Related]
65. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.
Henderson BW; Fingar VH
Cancer Res; 1987 Jun; 47(12):3110-4. PubMed ID: 3581062
[TBL] [Abstract][Full Text] [Related]
66. Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
Rogers GS
J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S14-7. PubMed ID: 23055207
[TBL] [Abstract][Full Text] [Related]
67. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
68. Using white light during photodynamic therapy: visualization only or treatment?
Mordon S; Maunoury V
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):765-71. PubMed ID: 16772834
[TBL] [Abstract][Full Text] [Related]
69. Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.
Veenhuizen RB; Marijnissen JP; Kenemans P; Ruevekamp-Helmers MC; 't Mannetje LW; Helmerhorst TJ; Stewart FA
Br J Cancer; 1996 Jun; 73(11):1387-92. PubMed ID: 8645584
[TBL] [Abstract][Full Text] [Related]
70. Dosimetry study of PHOTOFRIN-mediated photodynamic therapy in a mouse tumor model.
Qiu H; Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2016 Feb; 9694():. PubMed ID: 27053822
[TBL] [Abstract][Full Text] [Related]
71. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
[TBL] [Abstract][Full Text] [Related]
72. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
Cecic I; Stott B; Korbelik M
Int Immunopharmacol; 2006 Aug; 6(8):1259-66. PubMed ID: 16782538
[TBL] [Abstract][Full Text] [Related]
73. Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.
Wang LW; Huang Z; Lin H; Li ZS; Hetzel F; Liu Md B
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):244-251. PubMed ID: 23993850
[TBL] [Abstract][Full Text] [Related]
74. Photodynamic therapy of brain tumors--a work in progress.
Muller PJ; Wilson BC
Lasers Surg Med; 2006 Jun; 38(5):384-9. PubMed ID: 16788926
[TBL] [Abstract][Full Text] [Related]
75. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
Karotki A; Khurana M; Lepock JR; Wilson BC
Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
[TBL] [Abstract][Full Text] [Related]
76. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
77. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
78. Photodynamic therapy induces an immune response against a bacterial pathogen.
Huang YY; Tanaka M; Vecchio D; Garcia-Diaz M; Chang J; Morimoto Y; Hamblin MR
Expert Rev Clin Immunol; 2012 Jul; 8(5):479-94. PubMed ID: 22882222
[TBL] [Abstract][Full Text] [Related]
79. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
80. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
